Related Experiment Video
Updated: May 5, 2026

Development of a Multicellular Three-dimensional Organotypic Model of the Human Intestinal Mucosa Grown Under Microgravity
Published on: July 25, 2016
Characterization of an in vitro model of intestinal cells as a test-bed for mCIPO therapies
Abstract:
Chronic Intestinal Pseudo-Obstruction in children (CIPO) comprises a group of ultra-rare and debilitating diseases characterized by severe motility defects affecting the entire digestive tract. With limited effective therapies, particularly for myopathic CIPO, we aim at characterizing the behavior of an intestinal smooth muscle cell line undergoing a set of chemical and physical stimulations, to assess their effect. To this end, we adopted healthy Human Intestinal Smooth Muscle Cells, plated on standard coverslips and, for the first time, Micro Electrode Arrays (MEAs). After obtaining stable cultures, we performed pharmacological and electrical stimulation, evaluating the contraction level as readout. We found an increase in the contraction levels ascribable to stimulation respect to basal condition. Our results can be considered introductory for new therapies for treating intestine motility disorders.
Insights
Researchers studied human intestinal smooth muscle cells to understand motility disorders in children. Chemical and electrical stimulations increased cell contraction, offering insights for new therapies for Chronic Intestinal Pseudo-Obstruction.
Area of Science:
- Gastroenterology and Cell Biology
- Investigating the cellular mechanisms of gastrointestinal motility disorders.
Background:
- Chronic Intestinal Pseudo-Obstruction (CIPO) is a group of rare, severe diseases affecting children's digestive tract motility.
- Current therapies for CIPO, especially myopathic forms, are limited, necessitating research into underlying cellular functions.
Purpose of the Study:
- To characterize the contractile behavior of human intestinal smooth muscle cells under various stimulations.
- To explore potential cellular targets for novel therapeutic interventions in CIPO.
Main Methods:
- Utilized healthy Human Intestinal Smooth Muscle Cells cultured on Micro Electrode Arrays (MEAs).
- Applied pharmacological and electrical stimulations to assess cellular responses.
- Quantified contraction levels as a primary readout of cellular activity.
Main Results:
- Stimulation significantly increased intestinal smooth muscle cell contraction compared to basal conditions.
- Demonstrated the utility of MEAs for evaluating intestinal smooth muscle cell contractility.
- Established a cellular model for studying intestinal motility defects.
Conclusions:
- Cellular stimulation effectively modulates intestinal smooth muscle contractility.
- Findings provide a foundation for developing new therapeutic strategies for motility disorders.
- This research opens avenues for improved treatments for pediatric CIPO.

